Intec Pharma Ltd. — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2020)

-$14.1M

Total Assets (FY2020)

$20.9M

Total Equity (FY2020)

$14.5M

Cash Flows from Operating Activities (FY2020)

-$11.5M

Source: Intec Pharma Ltd. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.